Ignite Creation Date:
2024-05-06 @ 4:30 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05007236
Status:
COMPLETED
Last Update Posted:
2022-04-21
First Post:
2021-08-09
Brief Title:
Study to Evaluate the Efficacy and Safety of Oral RP7214 a DHODH Inhibitor in Patients With Symptomatic Mild COVID-19 Infection
Sponsor:
Organization:
Rhizen Pharmaceuticals SA
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
163
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: